Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ulenistamab (PBP1510)
i
Other names:
PBP1510
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Prestige BioPharma
Drug class:
ZG16B inhibitor
‹
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
PBP1510
Sensitive: B - Late Trials
PBP1510
Sensitive
:
B
PBP1510
Sensitive: B - Late Trials
PBP1510
Sensitive
:
B
ZG16B positive
Prostate Cancer
ZG16B positive
Prostate Cancer
PBP1510
Sensitive: D – Preclinical
PBP1510
Sensitive
:
D
PBP1510
Sensitive: D – Preclinical
PBP1510
Sensitive
:
D
ZG16B expression
Ovarian Cancer
ZG16B expression
Ovarian Cancer
PBP1510
Sensitive: D – Preclinical
PBP1510
Sensitive
:
D
PBP1510
Sensitive: D – Preclinical
PBP1510
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.